NCT00087880View on ClinicalTrials.gov

Maintaining Abstinence in Chronic Cigarette Smokers - 1

PHASE2CompletedINTERVENTIONAL

Enrollment

407

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

January 31, 2005

Study Completion Date

September 30, 2009

Conditions

Tobacco Use Disorder

Interventions

DRUG

Bupropion and NRT

All participants receive standard 12 week treatment of NRT, bupropion and five group counseling sessions. At week 11, subjects are randomly assigned to one of five treatment groups (1) Bupropion/Low Contact; (2) Placebo/Low Contact; (3) Bupropion/Relapse Prevention; (4) Placebo/Relapse Prevention; (5) No Further Treatment. Data is collected at Week 0, and at weeks 12, 24, 52, 64, and 104.

Trial Locations (1)

94143-0984

University California, San Francisco, San Francisco

All Listed Sponsors

lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00087880 - Maintaining Abstinence in Chronic Cigarette Smokers - 1 | Biotech Hunter | Biotech Hunter